EIM
CLPT icon

Essex Investment Management’s ClearPoint Neuro CLPT Stock Holding History

Essex Investment Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-232,458
Closed -$5.07M – 311
2025
Q3 		$5.07M Sell
232,458
-92,920
-29% -$1.09M 0.78% 35
2025
Q2 		$3.89M Sell
325,378
-2,081
-0.6% -$26.2K 0.71% 44
2025
Q1 		$3.89M Sell
327,459
-81,363
-20% -$1.26M 0.81% 34
2024
Q4 		$6.29M Sell
408,822
-55,031
-12% -$713K 1.13% 18
2024
Q3 		$5.2M Buy
463,853
+1,267
+0.3% +$12.1K 0.91% 29
2024
Q2 		$2.49M Buy
462,586
+132,707
+40% +$768K 0.47% 82
2024
Q1 		$2.24M Buy
+329,879
New +$2.31M 0.44% 93
2023
Q2 		– Sell
-196,092
Closed -$1.66M – 378
2023
Q1 		$1.66M Buy
196,092
+28,063
+17% +$246K 0.24% 132
2022
Q4 		$1.42M Sell
168,029
-910
-0.5% -$8.63K 0.22% 144
2022
Q3 		$1.75M Buy
168,939
+63,349
+60% +$835K 0.28% 113
2022
Q2 		$1.38M Buy
+105,590
New +$1.08M 0.22% 133

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
FCM
FirstWave Capital Management Miami, Florida $227M AUM
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Essex Investment Management's CLPT Position: Q4 2025 in Review

Essex Investment Management sold out of ClearPoint Neuro (CLPT) in Q4 2025, closing a stake of 232,458 shares — an estimated $5.07M sold.

Essex Investment Management first reported a position in CLPT in Q2 2022 and held it in 11 quarters. The position peaked at $6.29M in Q4 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q4 2025.

  • Essex Investment Management reported no remaining ClearPoint Neuro position as of Q4 2025 after selling out during the quarter.
  • Essex Investment Management sold 232,458 ClearPoint Neuro shares in Q4 2025, an estimated $5.07M.
  • Essex Investment Management first reported a position in ClearPoint Neuro in Q2 2022 and held it in 11 quarters.
  • Essex Investment Management's ClearPoint Neuro position peaked at $6.29M in Q4 2024.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2025.

Based on Essex Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.